Serum selenium and risk of prostate cancer - a nested case-control study<sup>1-3</sup>
U. Peters(University of Washington), Richard B. Hayes(New York University), Nilanjan Chatterjee(Johns Hopkins University), Gerald L. Andriole(Institut thématique Génétique, génomique et bioinformatique), Douglas J. Reding(Ascension), E. David Crawford(University of Colorado Boulder), Stephen J. Chanock(National Institutes of Health), Charles B. Foster(Cleveland Clinic), Arthur Schatzkin(National Institutes of Health), Stefan Stürup(National Institutes of Health)
Research at the University of Copenhagen (University of Copenhagen)
January 1, 2007
Cited by 0
Related Papers
Mortality Results from a Randomized Prostate-Cancer Screening Trial
|New England Journal of Medicine|2009|2.9k
Chronic Granulomatous Disease: Report on a National Registry of 368 Patients
|Medicine|2000|1.7k
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer
|Nature Genetics|2007|1.5k
Genome-wide association study of prostate cancer identifies a second risk locus at 8q24
|Nature Genetics|2007|1.1k
Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up
|JNCI Journal of the National Cancer Institute|2012|1.1k